Content about Headache

May 21, 2013
Impax ships authorized generic version of Zomig

Impax Labs has launched an authorized generic drug for migraine headaches under a partnership with AstraZeneca, Impax said.

HAYWARD, Calif. — Impax Labs has launched an authorized generic drug for migraine headaches under a partnership with AstraZeneca, Impax said.

Impax said its generics division, Global Pharmaceuticals, began shipping authorized generic zolmitriptan tablets and orally disintegrating tablets in the 2.5 mg and 5 mg strengths. The drug is a version of AstraZeneca's Zomig.

Zomig had sales of about $196 million during the 12-month period that ended in April, according to IMS Health.

November 28, 2012
OTCs popular choice to treat both acute and chronic maladies

Consumers are increasingly turning to OTCs to treat their conditions, including both acute, episodic conditions like the common cold and such chronic conditions as frequent pain and allergy. However, the extent to which OTCs are used varies by condition, according to an online survey of more than 900 AccentHealth viewers conducted in September. Headache sufferers reported using OTC medications most often (89%), while sufferers of certain digestive disorders use OTCs less often (53%).

Consumers are increasingly turning to OTCs to treat their conditions, including both acute, episodic conditions like the common cold and such chronic conditions as frequent pain and allergy. However, the extent to which OTCs are used varies by condition, according to an online survey of more than 900 AccentHealth viewers conducted in September. Headache sufferers reported using OTC medications most often (89%), while sufferers of certain digestive disorders use OTCs less often (53%).

To see more Patient Views, click here.

September 14, 2012
FDA approves Lannett tension headache drug

The Food and Drug Administration has granted regulatory approval for a generic drug to treat tension headaches.

PHILADELPHIA — The Food and Drug Administration has granted regulatory approval for a generic drug to treat tension headaches.

Lannett announced the approval of butalbital, acetaminophen and caffeine tablets in the 50-mg/325-mg/40-mg strength. the drug is a generic version of Watson Pharmaceuticals' Fioricet.

Branded and generic versions of the drug had sales of $30 million during the 12-month period ended in July, including $15 million for branded Fioricet. Lannett plans to start shipping its version next month, the company said.